Hqlsey Quit Smoking Patches Patch
NDC Package 87405-001-01
Package Information
Hqlsey Quit Smoking Patches (quit smoking patches) patches is ·if you smoke more than 10 cigarettes per day: -use Step 1 (21 mg) patch for weeks 1-6 ·apply one patch to a clean, dry, hairless area of skin on the upper body or outer part of the arm ·press patch frmly in place for about 10 seconds ·wash hands after applying or removing patch ·apply a new patch each day to a different area of skin ·do not use more than one patch at a time ·remove patch after 24 hours. This formulation utilizes a patch delivery system. Marketed by Hansen Pharmaceutical Investment Co., Limited, this product is identified by NDC 87405-001 and is authorized under FDA application M017.
Identification & Billing
- RxCUI: 198030 - nicotine 21 MG/Day 24HR Transdermal System
- RxCUI: 198030 - 24 HR nicotine 0.875 MG/HR Transdermal System
- RxCUI: 198030 - nicotine 0.875 MG/HR 24HR Transdermal Patch
- RxCUI: 198030 - nicotine 21 MG per 24HR 1 Day Transdermal Patch
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 87405 - Hansen Pharmaceutical Investment Co., Limited
- 87405-001 - Hqlsey Quit Smoking Patches
- 87405-001-01 - 14 PATCH in 1 BOX
- 87405-001 - Hqlsey Quit Smoking Patches
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 87405-001-01 identifies a specific commercial package of 14 patch in 1 box of Hqlsey Quit Smoking Patches, a human over the counter drug labeled by Hansen Pharmaceutical Investment Co., Limited. This patch is formulated for topical use and contains nicotine as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Hansen Pharmaceutical Investment Co., Limited on February 25, 2026. The current certification is valid through December 31, 2027.
How is this Hansen Pharmaceutical Investment Co., Limited product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 87405000101. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.